NNIT is 100%-owned by Novo Nordisk. At NNIT, we work within the framework of Novo Nordisk’s vision, values, obligations and basic management principles. Together, we call these elements the Novo Nordisk Charter.

Novo Nordisk A/S

Novo Nordisk is one of the world’s leading companies in the field of diabetic treatment. Novo Nordisk has the industry’s broadest assortment of diabetic products – including the most advanced systems for administering insulin.

In addition, Novo Nordisk maintains a leadership position in other areas such as the treatment of bleeding, growth hormone treatment, and hormone preparations for the treatment of menopausal problems. Today, Novo Nordisk employs over 23,000 people in 79 countries, of which some 60% work in Denmark.

Novo Nordisk has a long history, dating right back to 1922. Here you can read about the company’s milestones.